Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 6/20 | 0.34 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.33 |
| ▸ | PREP | P48147 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL208987 | 0.93 | PRKCA (0.35) | PRKCAKMT2ASMN1; SMN2 | |
| SCHEMBL208988 | 0.87 | TSHR (0.36) | PRKCAKMT2A | |
| SCHEMBL29293697 | 0.85 | PRKCA (0.38) | PRKCAKMT2ASMN1; SMN2 | |
| SCHEMBL16790693 | 0.83 | PRKCA (0.31) | PRKCA | |
| SCHEMBL9914760 | 0.82 | PTGS1 (0.47) | SMN1; SMN2 | |
| SCHEMBL20375257 | 0.82 | FKBP1A (0.39) | KMT2A | |
| SCHEMBL15281651 | 0.81 | PRKCA (0.32) | PRKCAPAOXPREP | |
| SCHEMBL18308882 | 0.81 | SMN1; SMN2 (0.34) | PRKCAKMT2ASMN1; SMN2 | |
| SCHEMBL26263126 | 0.81 | TBXAS1 (0.30) | KMT2A | |
| SCHEMBL12457816 | 0.80 | FAAH (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150238597-A1 | CARBOHYDRATE-GLYCOLIPID CONJUGATE VACCINES | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2015-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150238597-A1 | CARBOHYDRATE-GLYCOLIPID CONJUGATE VACCINES | STT3B, STT3A, DDOST | PRKCA 1696/4885PAOX 762/4885PREP 940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.